Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引:179
|
作者
Bonoto, Braulio Cezar [1 ]
de Araujo, Vania Eloisa [2 ]
Godoi, Isabella Piassi [1 ,3 ]
Pires de Lemos, Livia Lovato [3 ,4 ]
Godman, Brian [5 ,6 ]
Bennie, Marion [5 ]
Diniz, Leonardo Mauricio [7 ]
Guerra Junior, Augusto Afonso [1 ,3 ]
机构
[1] Univ Fed Minas Gerais, Dept Social Pharm, Post Grad Program Med & Pharmaceut Assistance, Av Presidente Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil
[2] Pontificia Univ Catolica Minas Gerais, Fac Odontol, Inst Biol Sci & Hlth, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Social Pharm, SUS Collaborating Ctr Technol Assessment & Excell, Belo Horizonte, MG, Brazil
[4] Univ Fed Minas Gerais, Dept Prevent & Social Med, Post Grad Program Publ Hlth, Belo Horizonte, MG, Brazil
[5] Univ Strathclyde, Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
[6] Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacl, Stockholm, Sweden
[7] Univ Fed Minas Gerais, Dept Clin Med, Fac Med, Belo Horizonte, MG, Brazil
来源
JMIR MHEALTH AND UHEALTH | 2017年 / 5卷 / 03期
关键词
diabetes mellitus; self-care; mobile applications; telemedicine; SELF-MANAGEMENT; GLYCEMIC CONTROL; HEALTH-CARE; INTERVENTION; TECHNOLOGY; PHONE; IMPACT; HYPERTENSION; PERSISTENCE; ACCEPTANCE;
D O I
10.2196/mhealth.6309
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Diabetes Mellitus (DM) is a chronic disease that is considered a global public health problem. Education and self-monitoring by diabetic patients help to optimize and make possible a satisfactory metabolic control enabling improved management and reduced morbidity and mortality. The global growth in the use of mobile phones makes them a powerful platform to help provide tailored health, delivered conveniently to patients through health apps. Objective: The aim of our study was to evaluate the efficacy of mobile apps through a systematic review and meta-analysis to assist DM patients in treatment. Methods: We conducted searches in the electronic databases MEDLINE (Pubmed), Cochrane Register of Controlled Trials (CENTRAL), and LILACS (Latin American and Caribbean Health Sciences Literature), including manual search in references of publications that included systematic reviews, specialized journals, and gray literature. We considered eligible randomized controlled trials (RCTs) conducted after 2008 with participants of all ages, patients with DM, and users of apps to help manage the disease. The meta-analysis of glycated hemoglobin (HbA1c) was performed in Review Manager software version 5.3. Results: The literature search identified 1236 publications. Of these, 13 studies were included that evaluated 1263 patients. In 6 RCTs, there were a statistical significant reduction (P<.05) of HbA1c at the end of studies in the intervention group. The HbA1c data were evaluated by meta-analysis with the following results (mean difference, MD -0.44; CI: -0.59 to -0.29; P<.001; I-2 = 32%). The evaluation favored the treatment in patients who used apps without significant heterogeneity. Conclusions: The use of apps by diabetic patients could help improve the control of HbA1c. In addition, the apps seem to strengthen the perception of self-care by contributing better information and health education to patients. Patients also become more self-confident to deal with their diabetes, mainly by reducing their fear of not knowing how to deal with potential hypoglycemic episodes that may occur.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Efficacy and safety of intermittent fasting for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized trials
    Chadwick, Joshua
    Ayyasamy, Lavanya
    Kalyanasundaram, Madhanraj
    Parasuraman, Ganeshkumar
    Bagepally, Bhavani Shankara
    Kathiresan, Jeyashree
    Shanmugam, Lokesh
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2025, 17
  • [32] Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Greff, Dorina
    Vancsa, Szilard
    Varadi, Alex
    Szinte, Julia
    Park, Sunjune
    Hegyi, Peter
    Nyirady, Peter
    Acs, Nandor
    Horvath, Eszter Maria
    Varbiro, Szabolcs
    NUTRIENTS, 2023, 15 (19)
  • [33] Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wei, Jingshu
    Yan, Jie
    Yang, Huixia
    NUTRIENTS, 2022, 14 (14)
  • [34] Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Bhattacharya, Saptarshi
    Nagendra, Lakshmi
    Dutta, Deep
    Kamrul-Hasan, A. B. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [35] Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Feng, Miao
    Lv, Haihong
    Xu, Xia
    Wang, Jue
    Lyu, Wenyi
    Fu, Songbo
    MEDICINE, 2019, 98 (30)
  • [36] Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Hagi, Katsuhiko
    Nitta, Masahiro
    Watada, Hirotaka
    Kaku, Kohei
    Ueki, Kohjiro
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (11) : 1246 - 1261
  • [37] Efficacy and safety of empagliflozin for type 2 diabetes mellitus Meta-analysis of randomized controlled trials
    Zhang, Yun-Jing
    Han, Shi-Liang
    Sun, Xi-Feng
    Wang, Shu-Xiang
    Wang, Hong-Yun
    Liu, Xiao
    Chen, Li
    Xia, Ling
    MEDICINE, 2018, 97 (43)
  • [38] Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Khan, Parvej
    Venkatesh, Shubhashree
    Parveen, Rizwana
    Mishra, Pinki
    Jain, Seema
    Agarwal, Nidhi
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2199 - 2210
  • [39] Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    Devi, R.
    Mali, Ghanshyam
    Chakraborty, Indrani
    Unnikrishnan, Mazhuvancherry Kesavan
    Abdulsalim, Suhaj
    POSTGRADUATE MEDICINE, 2017, 129 (03) : 382 - 392
  • [40] Efficacy and safety of ACEI/ARB drugs in patients with COVID-19 combined with diabetes mellitus A protocol for systematic review and meta-analysis of randomized controlled trials
    Yang, Yan
    Liu, Xiaoke
    Liu, Yan
    Chen, Yalin
    Tian, Yuan
    Fu, Xiaoxu
    Zhong, Wen
    Xie, Chunguang
    MEDICINE, 2020, 99 (35)